Prosecution Insights
Last updated: May 29, 2026

National Cancer Center

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
1
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (75%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (75%)
§112 only1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VISHNYAKOVA, ELENA VLADIMIROVNA 1 59.3% +73.3%
FAIRCHILD, AARON BENJAMIN 1 79.1% +20.6%
ARMATO JR, DENNIS IGNATIUS 1 56.3% +70.0%
ABBASI, ABDUL HADI 1 0.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18105300 ENDOSCOPE SYSTEM, CONTROLLER, CONTROL METHOD, AND RECORDING MEDIUM ABBASI, ABDUL HADI 27d

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19177218 TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE VISHNYAKOVA, ELENA VLADIMIROVNA 60d overdue
18583630 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM FAIRCHILD, AARON BENJAMIN 28d
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 84d

Top Art Units

Art UnitApps
3795 2
1691 1
1651 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19177218 TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §103 Final Rejection 60d overdue Pending Apr 11, 2025
18583630 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM FAIRCHILD, AARON BENJAMIN 3795 §112 Non-Final OA 28d Pending Feb 21, 2024
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 1651 §103 Final Rejection 84d Pending Apr 27, 2023
18105300 ENDOSCOPE SYSTEM, CONTROLLER, CONTROL METHOD, AND RECORDING MEDIUM ABBASI, ABDUL HADI 3795 §103 Final Rejection 27d Pending Feb 03, 2023

Managing National Cancer Center's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month